White blood cell count and all-cause and cause-specific mortality in the Guangzhou biobank cohort study
- PMID: 30400967
- PMCID: PMC6219250
- DOI: 10.1186/s12889-018-6073-6
White blood cell count and all-cause and cause-specific mortality in the Guangzhou biobank cohort study
Abstract
Background: Several studies have shown positive associations between higher WBC count and deaths from all-causes, CHD, stroke and cancer among occidental populations or developed countries of Asia. No study on the association of WBC count with all-cause and cause-specific mortality in Chinese populations was reported. We studied this using prospective data from a large Chinese cohort.
Methods: We used prospective data from the Guangzhou Biobank Cohort Study (GBCS), a total of 29,925 participants in present study. A Cox proportional hazards regression model was used to estimate the hazard ratios (HR) and 95% confidence interval (CI).
Results: The hazard ratios (HR) for all-cause, CHD, and respiratory disease mortality for the highest decile of WBC count (women > 8.2 × 109/L; men > 8.8 × 109/L) was 1.83 (95% confidence interval (CI) 1.54, 2.17), 3.02 (95% CI 1.84, 4.98) and 2.52 (95% CI 1.49, 4.27), respectively, after adjusting for multiple potential confounders. The associations were similar when deaths during the first 2 years of follow-up were excluded. After further adjusting for pulmonary function, the highest decile of WBC count was associated with 90% higher risk of respiratory disease mortality (HR 1.90, 95% CI 1.08, 3.33). No evidence for an association between higher WBC count and cancer mortality was found. Sub-type analysis showed that only granulocyte count remained significantly predictive of all-cause, CHD, and respiratory disease mortality.
Conclusions: Elevated WBC, specifically granulocyte, count was associated with all-cause, CHD and respiratory mortality in southern Chinese. Further investigation is warranted to clarify whether decreasing inflammation would attenuate WBC count associated mortality.
Keywords: All-cause mortality; Cause-specific mortality; Granulocyte count; Prospective cohort study; White blood cell count.
Conflict of interest statement
Ethics approval and consent to participate
The GBCS was approved by Guangzhou Medical Ethics Committee of the Chinese Medical Association. All participants provided written, informed consent before participation.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.Arch Intern Med. 2005 Mar 14;165(5):500-8. doi: 10.1001/archinte.165.5.500. Arch Intern Med. 2005. PMID: 15767524
-
White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese--results from the NIPPON DATA90.Circ J. 2007 Apr;71(4):479-85. doi: 10.1253/circj.71.479. Circ J. 2007. PMID: 17384446
-
White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative.Am J Epidemiol. 2017 Jul 1;186(1):63-72. doi: 10.1093/aje/kww226. Am J Epidemiol. 2017. PMID: 28369251 Free PMC article.
-
Higher total white blood cell and neutrophil counts are associated with an increased risk of fatal stroke occurrence: the Guangzhou biobank cohort study.BMC Neurol. 2021 Dec 2;21(1):470. doi: 10.1186/s12883-021-02495-z. BMC Neurol. 2021. PMID: 34856939 Free PMC article.
-
The Prognostic Significance of Leukocyte Count on All-Cause and Cardiovascular Disease Mortality: A Systematic Review and Meta-Analysis.Am J Cardiol. 2023 Sep 15;203:226-233. doi: 10.1016/j.amjcard.2023.06.119. Epub 2023 Jul 26. Am J Cardiol. 2023. PMID: 37506668
Cited by
-
A Simple Model for Predicting 10-Year Cardiovascular Risk in Middle-Aged to Older Chinese: Guangzhou Biobank Cohort Study.J Cardiovasc Transl Res. 2022 Apr;15(2):416-426. doi: 10.1007/s12265-021-10163-3. Epub 2021 Aug 16. J Cardiovasc Transl Res. 2022. PMID: 34402029 Clinical Trial.
-
Prediction model for cardiovascular disease risk in hemodialysis patients.Int Urol Nephrol. 2022 May;54(5):1127-1134. doi: 10.1007/s11255-021-02984-7. Epub 2021 Sep 6. Int Urol Nephrol. 2022. PMID: 34487297
-
Associations of soy product intake with all-cause, cardiovascular disease and cancer mortality: Guangzhou Biobank Cohort Study and updated meta-analyses.Eur J Nutr. 2024 Aug;63(5):1731-1745. doi: 10.1007/s00394-024-03363-5. Epub 2024 Mar 23. Eur J Nutr. 2024. PMID: 38520523
-
Development and validation of an in-hospital major adverse cardiovascular events risk model for young patients with acute coronary syndrome: a retrospective cohort study.PeerJ. 2025 May 26;13:e19513. doi: 10.7717/peerj.19513. eCollection 2025. PeerJ. 2025. PMID: 40444287 Free PMC article.
-
Association Between the Glucose-to-Lymphocyte Ratio and 28-Day Mortality in Patients with Mechanical Ventilation.Balkan Med J. 2025 Jul 1;42(4):358-366. doi: 10.4274/balkanmedj.galenos.2025.2025-2-49. Balkan Med J. 2025. PMID: 40619841 Free PMC article.
References
-
- Tamakoshi K, Toyoshima H, Yatsuya H, Matsushita K, Okamura T, Hayakawa T, Okayama A, Ueshima H, Group NDR White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese—results from the NIPPON DATA90. Circ J. 2007;71(4):479–485. doi: 10.1253/circj.71.479. - DOI - PubMed
MeSH terms
Grants and funding
- SN/1f/HKUF-DC; C20400.28505200/The University of Hong Kong Foundation for Educational Development and Research
- HMRF/13143241/the Health Medical Research Fund in HongKong
- 201102A211004011/the Guangzhou Public Health Bureau
- 2002Z2-E2051; 2012J5100041; 2013J4100031/the Guangzhou Science and Technology Bureau
- 2015A030313891/Natural Science Foundation of Guangdong and the University of Birmingham
LinkOut - more resources
Full Text Sources